Latest Market News

KMD Brands has wrapped up a fully underwritten entitlement offer and placement, raising NZ$65.3 million to reduce net debt and shore up its balance sheet ahead of executing its growth plans.

Mercury has lifted its FY2026 EBITDAF guidance by 5%, citing better-than-expected renewable generation from hydro and new assets. The upgrade signals disciplined portfolio management but remains sensitive to hydrological variability.

Jindalee Lithium is set to list its McDermitt lithium project on NASDAQ through a US SPAC deal valuing the assets at US$571 million, while securing key US federal approvals and advancing magnesium by-product potential.

Firebrick Pharma secured regulatory approval for Nasodine Nasal Spray in Indonesia and launched Nasodine Throat Spray in Singapore and Fiji, while raising $1.5 million to fuel growth. The company aims to quadruple its product and market footprint within three years.

Energy Action Limited posted a milestone quarter ending March 2026, delivering positive operating cash flow for the first time in FY26 alongside strong revenue gains and a notable $0.5 million debt repayment. Governance changes add a layer of uncertainty ahead of a scheduled general meeting.

Metro Mining Limited (ASX:MMI) is set to reduce its share count drastically through a 20-for-1 consolidation, pending shareholder approval at the upcoming AGM. This move will slash its ordinary shares from over 6 billion to just over 300 million, reshaping its capital structure.

Elixinol Wellness maintained steady revenue at $3.5 million in Q1 FY26 while boosting gross margins to 45% and reporting a second consecutive quarter of positive underlying operating cash flow.

Rand Mining delivered its March 2026 quarter exploration update for the East Kundana Joint Venture, highlighting 8,831 metres of diamond drilling focused on the Golden Hind and Startrek deposits. While Golden Hind assay results confirmed ongoing mineralisation with no resource update, Startrek drilling progressed with assays awaited.

Kalamazoo Resources reported a robust cash balance of AUD 8.8 million at quarter end, underpinned by a significant equity raise that offsets ongoing exploration and administrative outflows. The company’s funding runway extends beyond three quarters, positioning it to advance its Ashburton Gold Project drilling activities.

Recce Pharmaceuticals has cleared a critical regulatory hurdle in Indonesia with a successful inspection of its Phase 3 clinical trial site for diabetic foot infections, paving the way for potential approval in 2026 amid a large and growing market.

Australian Silica Quartz Group (ASQ) is set to acquire Australian Kaolin, adding a 47Mt inferred kaolin resource at White Swan and launching a $750,000 placement to fund development. The deal hinges on shareholder approval and an Independent Expert’s fairness opinion.

The L1 Global Long Short Fund (ASX:GLS) faced a challenging March quarter amid the Iran War-driven oil supply shock but maintains strong performance since inception through active portfolio adjustments and thematic focus on copper, gold, and infrastructure.